• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类类器官对新冠病毒的防御作用

Defense of COVID-19 by Human Organoids.

作者信息

Lv Ting, Meng Fanlu, Yu Meng, Huang Haihui, Lin Xinhua, Zhao Bing

机构信息

State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, 200438 China.

Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, 200040 China.

出版信息

Phenomics. 2021;1(3):113-128. doi: 10.1007/s43657-021-00015-0. Epub 2021 Jul 14.

DOI:10.1007/s43657-021-00015-0
PMID:35233559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8277987/
Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has created an immense menace to public health worldwide, exerting huge effects on global economic and political conditions. Understanding the biology and pathogenesis mechanisms of this novel virus, in large parts, relies on optimal physiological models that allow replication and propagation of SARS-CoV-2. Human organoids, derived from stem cells, are three-dimensional cell cultures that recapitulate the cellular organization, transcriptional and epigenetic signatures of their counterpart organs. Recent studies have indicated their great values as experimental virology platforms, making human organoid an ideal tool for investigating host-pathogen interactions. Here, we summarize research developments for SARS-CoV-2 infection of various human organoids involved in multiple systems, including lung, liver, brain, intestine, kidney and blood vessel organoids. These studies help us reveal the pathogenesis mechanism of COVID-19, and facilitate the development of effective vaccines and drugs as well as other therapeutic regimes.

摘要

2019冠状病毒病(COVID-19)由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起,对全球公共卫生构成了巨大威胁,对全球经济和政治状况产生了巨大影响。在很大程度上,了解这种新型病毒的生物学特性和发病机制依赖于能够支持SARS-CoV-2复制和传播的最佳生理学模型。源自干细胞的人类类器官是三维细胞培养物,可概括其对应器官的细胞组织、转录和表观遗传特征。最近的研究表明它们作为实验病毒学平台具有巨大价值,使人类类器官成为研究宿主-病原体相互作用的理想工具。在此,我们总结了SARS-CoV-2感染多种涉及多个系统的人类类器官的研究进展,包括肺、肝、脑、肠、肾和血管类器官。这些研究有助于我们揭示COVID-19的发病机制,并促进有效疫苗、药物及其他治疗方案的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/9590567/857f8fc1f78a/43657_2021_15_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/9590567/9fefe5946581/43657_2021_15_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/9590567/518f4867cc91/43657_2021_15_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/9590567/857f8fc1f78a/43657_2021_15_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/9590567/9fefe5946581/43657_2021_15_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/9590567/518f4867cc91/43657_2021_15_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c922/9590567/857f8fc1f78a/43657_2021_15_Fig3_HTML.jpg

相似文献

1
Defense of COVID-19 by Human Organoids.人类类器官对新冠病毒的防御作用
Phenomics. 2021;1(3):113-128. doi: 10.1007/s43657-021-00015-0. Epub 2021 Jul 14.
2
Human Organoids as a Promising Platform for Fighting COVID-19.类器官在抗击 COVID-19 中的应用
Int J Biol Sci. 2022 Jan 1;18(3):901-910. doi: 10.7150/ijbs.64993. eCollection 2022.
3
The Human Nose Organoid Respiratory Virus Model: an Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics.人呼吸道类器官病毒模型:用于研究呼吸道合胞病毒(RSV)和严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)发病机制及评估治疗方法的人体挑战模型。
mBio. 2021 Feb 22;13(1):e0351121. doi: 10.1128/mbio.03511-21. Epub 2022 Feb 15.
4
Lung Organoids as Model to Study SARS-CoV-2 Infection.肺类器官作为研究 SARS-CoV-2 感染的模型。
Cells. 2022 Sep 4;11(17):2758. doi: 10.3390/cells11172758.
5
Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.人器官型气道和肺泡分化的肺类器官细胞允许流感和 SARS-CoV-2 呼吸道病毒感染。
Front Cell Infect Microbiol. 2022 Mar 14;12:841447. doi: 10.3389/fcimb.2022.841447. eCollection 2022.
6
Human organoid models to study SARS-CoV-2 infection.人类类器官模型用于研究 SARS-CoV-2 感染。
Nat Methods. 2022 Apr;19(4):418-428. doi: 10.1038/s41592-022-01453-y. Epub 2022 Apr 8.
7
Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery.基于人多能干细胞的类器官和细胞平台用于模拟 SARS-CoV-2 感染和药物发现。
Stem Cell Res. 2021 May;53:102207. doi: 10.1016/j.scr.2021.102207. Epub 2021 Feb 20.
8
Stem cell-derived organoid models for SARS-CoV-2 and its molecular interaction with host cells.用于研究严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其与宿主细胞分子相互作用的干细胞衍生类器官模型
Mol Biol Rep. 2023 Dec;50(12):10627-10635. doi: 10.1007/s11033-023-08785-8. Epub 2023 Sep 23.
9
Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models.人类类器官模型中严重急性呼吸综合征相关冠状病毒2发病机制的研究综述。
Rev Med Virol. 2021 Nov;31(6):e2227. doi: 10.1002/rmv.2227. Epub 2021 Mar 25.
10
Human Organoids and Organs-on-Chips for Addressing COVID-19 Challenges.用于应对 COVID-19 挑战的人类类器官和器官芯片。
Adv Sci (Weinh). 2022 Apr;9(10):e2105187. doi: 10.1002/advs.202105187. Epub 2022 Feb 2.

引用本文的文献

1
TRβ activation confers AT2-to-AT1 cell differentiation and anti-fibrosis during lung repair via KLF2 and CEBPA.TRβ 激活通过 KLF2 和 CEBPA 赋予 AT2 向 AT1 细胞分化和抗纤维化作用,从而促进肺修复。
Nat Commun. 2024 Oct 7;15(1):8672. doi: 10.1038/s41467-024-52827-z.
2
Priority index for critical Covid-19 identifies clinically actionable targets and drugs.新冠肺炎危重症优先指标确定了具有临床可操作性的目标和药物。
Commun Biol. 2024 Feb 16;7(1):189. doi: 10.1038/s42003-024-05897-0.
3
Development of an RBD-Fc fusion vaccine for COVID-19.一种用于新型冠状病毒肺炎的受体结合域-融合蛋白(RBD-Fc)融合疫苗的研发。

本文引用的文献

1
Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection.生成人扁桃体上皮类器官作为 SARS-CoV-2 感染的体外模型。
Biomaterials. 2022 Apr;283:121460. doi: 10.1016/j.biomaterials.2022.121460. Epub 2022 Mar 7.
2
Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19.成体干细胞衍生的完整肺类器官模型模拟 COVID-19 中的肺部疾病。
Elife. 2021 Aug 13;10:e66417. doi: 10.7554/eLife.66417.
3
SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.
Vaccine X. 2024 Jan 21;16:100444. doi: 10.1016/j.jvacx.2024.100444. eCollection 2024 Jan.
4
Brain organoids for addressing COVID-19 challenge.用于应对新冠疫情挑战的脑类器官
Front Neurosci. 2022 Nov 29;16:1055601. doi: 10.3389/fnins.2022.1055601. eCollection 2022.
5
In vitro high-content tissue models to address precision medicine challenges.用于解决精准医学挑战的体外高通量组织模型。
Mol Aspects Med. 2023 Jun;91:101108. doi: 10.1016/j.mam.2022.101108. Epub 2022 Aug 17.
用于新冠病毒疾病建模和药物发现的原代人肺上皮细胞的严重急性呼吸综合征冠状病毒2感染
Cell Rep. 2021 May 4;35(5):109055. doi: 10.1016/j.celrep.2021.109055. Epub 2021 Apr 13.
4
The Organoid Platform: Promises and Challenges as Tools in the Fight against COVID-19.类器官平台:作为抗击 COVID-19 工具的前景与挑战。
Stem Cell Reports. 2021 Mar 9;16(3):412-418. doi: 10.1016/j.stemcr.2020.11.009.
5
Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids.利用人干细胞衍生的肺和脑类器官揭示组织特异性 SARS-CoV-2 感染和宿主反应。
Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005. Epub 2021 Feb 12.
6
Engineering organoids.工程化类器官
Nat Rev Mater. 2021;6(5):402-420. doi: 10.1038/s41578-021-00279-y. Epub 2021 Feb 19.
7
Cholangiocyte organoids can repair bile ducts after transplantation in the human liver.胆管细胞类器官可在人肝移植后修复胆管。
Science. 2021 Feb 19;371(6531):839-846. doi: 10.1126/science.aaz6964.
8
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide.TMPRSS2 表达的不同机制解释了恩扎卢胺对 SARS-CoV-2 感染的器官特异性抑制作用。
Nat Commun. 2021 Feb 8;12(1):866. doi: 10.1038/s41467-021-21171-x.
9
Neuroinvasion of SARS-CoV-2 in human and mouse brain.新冠病毒在人和鼠脑内的神经入侵。
J Exp Med. 2021 Mar 1;218(3). doi: 10.1084/jem.20202135.
10
Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.SARS-CoV-2 感染后人类气道和肺泡类器官中的宿主代谢失调和细胞嗜性鉴定。
Protein Cell. 2021 Sep;12(9):717-733. doi: 10.1007/s13238-020-00811-w. Epub 2020 Dec 12.